|
|
We Have Recently Made Changes to Our Website, If you are unable to find something Specific, Please Search Below
Publish Date : 9/10/2004 2:01:00 PM Source : SkinCareIndia Health News According to the American Heart Association, congenital cardiovascular defects, such as congenital heart disease (CHD),
are present in about one percent of live births and are the most common malformations in newborns. A team of University of Pennsylvania School of Medicine researchers, led by Edward E. Morrisey, PhD, Associate Professor of Medicine, have been investigating how the heart develops from its earliest stages of development to its late stages, with the hope of learning why some hearts don't develop correctly. Dr. Morrisey's latest finding – to be published in the September 10th issue of Science – may redefine current models of how the heart develops in mammals. "Understanding the earliest steps in heart development gives us insight into the possible genetic causes of the dramatic heart defects exhibited by so many newborn babies, " says Morrisey. During normal embryonic development in mammals, pre-cardiac cells form the bilateral cardiac primordia –two symmetrical, tube-shaped regions located on both sides of the early embryo. As cardiac development progresses, these two regions fuse, forming one large tube, which, in turn, further develops into the four-chamber heart. Using genetically engineered mice, Penn researchers successfully inactivated the Foxp4 binding protein, which resulted in the inability of the bilateral tubes to fuse. They found that each region of pre-cardiac cells still developed into a single tube, and then further developed into a four-chamber heart. This resulted in the mouse embryos developing two, four-chambered hearts exhibiting most aspects of advanced heart development. Eventually these embryos succumbed due to the lack of correct blood flow with two hearts pumping into the same set of blood vessels. Foxp4 belongs to a class of DNA binding proteins called transcription factors that turn other genes on and off. Interestingly, Foxp4 is not expressed in heart muscle cells themselves but rather in the primitive gut tube, which will develop into the stomach and intestines. In the early mammalian embryo, the gut tube helps direct the fusion of the two tubes of pre-cardiac cells into one tube. Dr. Morrisey thinks that expression of Foxp4 in the gut tube may be responsible for this lack of fusion: "Other mutations in genes expressed in the gut tube have led to similar results in simpler organisms such as zebrafish. What is remarkable about Foxp4 mutant mice is that their hearts develop to such a late stage. We have never been able to determine in mammals whether fusion of the bilateral heart tubes was required for later stages of development including formation of all four-heart chambers. Now we know it's not necessary". Another aspect of the work that is remarkable is that both of the hearts that form in Foxp4 mutant embryos show the same ability to distinguish left and right "sidedness". Many organs in the mammalian body have distinct left and right sides such as the heart and lung. In Foxp4 mutant embryos, both hearts show the correct "sidedness" regardless of whether they were on the right or left side of the embryo. The researchers suggest this work may be crucial in determining what gene mutations might lead to congenital cardiovascular defects. Cardiac development is conserved in mammals so defects in early cardiovascular development may lead to malformations in the human heart. "Although there have been no substantiated reports of humans born with two hearts, our understanding of how this very early process of fusion of the two bilateral cardiac primordial is regulated should provide a better understanding of many aspects of later heart development including those that are directly linked to congenital heart disease" says Morrisey. Other Penn researchers contributing to this study are Shanru Li, Deying Zhou and Min-Min Lu. This study was funded by grants from The National Institutes of Health and the American Heart Association. |
|
Cervical cancer vaccine breakthrough
Publish Date : 11/15/2004 1:16:00 PM Scientists say they have tested a vaccine, Cervarix, that protects women from two strains of HPV (human papillomavirus) which are responsible for 70% of cervical cancers. Beyond Tactical Struggles over Public Policy -The President's Council on Bioethics Publish Date : 11/15/2004 1:15:00 PM An on-stage discussion with William F May, PhD. Bioethicist and Author Human mad cow disease, there are many different forms of it Publish Date : 11/15/2004 1:15:00 PM Depending on your genetic makeup, vCJD (Varian Mad Cow Disease) will manifest itself differently, say researchers. This means vCJD may be present in some areas without being detected (vCJD means the human form of mad cow disease). New online tool kit on HIV/AIDS prevention for sex workers Publish Date : 11/15/2004 1:11:00 PM GTZ, WHO and sex work networks share information and lessons learned - The German technical cooperation (GTZ) and the World Health Organization (WHO), in collaboration with sex work networks around the world..... Anti-drug driving campaign wins award Publish Date : 11/10/2004 7:34:00 PM A road safety initiative to stop people driving under the influence of drugs has won an award at the THINK road safety conference. Text Messaging Helps Patients in Developing Countries Manage HIV/AIDS Treatment Publish Date : 11/10/2004 7:33:00 PM Wired News on Thursday examined how HIV/AIDS treatment counselors in countries where health care .... Roche Diagnostics Launches Highly-sensitive Polymerase Chain Reaction System Publish Date : 11/10/2004 7:32:00 PM Roche Diagnositcs has begun sales of it's real-time polymerase chain reaction (PCR) system LightCycler ST300, a highly-sensitive gene analysis system. 3 by 5 Initiative for HIV 'Probably Will Not' Meet Treatment Publish Date : 11/10/2004 7:31:00 PM The World Health Organization's 3 by 5 Initiative goal of treating three million HIV-positive people with antiretroviral ........ Manufacturing Approval for Statmark Influenza Virus Detection Reagent Publish Date : 11/10/2004 7:30:00 PM Nichirei (TSe: 2871), a leading Japanese food processing company, has announced that it has ..... US Health Improvements Slowing - Alarm at High Infant Mortality Rates and Obesity Publish Date : 11/10/2004 7:28:00 PM Although the overall health of US residents continues to improve, health indicators show that ... Total Results : 3044 More News (Opens in New Window) : [1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 Next Page |
|